Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/5/2010

SAN DIEGO, Nov. 5, 2010 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial results for the three and nine months ended September 30, 2010.

On November 2, Cadence announced that the U.S. Food and Drug Administration (FDA) approved OFIRMEV™ (acetaminophen) injection for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.

"We believe that there is a clear need for OFIRMEV in the U.S., as the classes of IV analgesics available to treat acute pain – opioids and NSAIDS – are associated with significant side effects. OFIRMEV is an important new treatment option that provides patients with significant pain relief while reducing opioid consumption," said Ted Schroeder, President and CEO of Cadence. "The approval of OFIRMEV marks Cadence's transition into a commercial enterprise poised to support the successful launch of our first product early in the first quarter of 2011."

Financial ResultsFor the three months ended September 30, 2010, Cadence reported a net loss of $11.7 million, or $0.23 per share, compared to a net loss of $11.4 million, or $0.23 per share, for the comparable period in 2009. For the nine months ended September 30, 2010, Cadence reported a net loss of $37.9 million, or $0.75 per share, compared to a net loss of $30.2 million, or $0.63 per share, for the comparable period in 2009.

Operating expenses for the three months ended September 30, 2010 decreased $0.2 million to $11.1 million, from the $11.3 million reported for the same period in 2009. This decrease was primarily a result of lower research and development spending and ge
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
10. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
11. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 The Cadence Fitness & Health Center ... the Medical Fitness Association, a non-profit organization assisting medically ... potential. The Cadence Fitness & Health Center is the ... second in the Chicagoland area. "The certification ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Global Markets ... -- Focus on End Users ... A drug delivery system is ...
(Date:1/14/2014)... Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... results for the fourth quarter of 2013 on Monday, February ... for release after the close of trading. ... conference call to discuss the operating highlights and financial results ...
Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... PDII ), today reported financial and operational results ... Summary financial and operating highlights include: Full year ... 2011 and 2010 revenue excludes the company,s Pharmakon business unit, ... in discontinued operations. Full year 2011 operating loss of $4.7 ...
... March 7, 2012  The Starkey Hearing Foundation Israel-Palestine Hearing ... Palestinians together for a common cause to address a ... a year, Starkey Hearing Foundation, which strives to change ... visited the region in an effort to promote greater ...
Cached Medicine Technology:PDI Reports 2011 Fourth Quarter and Year End Financial Results 2PDI Reports 2011 Fourth Quarter and Year End Financial Results 3PDI Reports 2011 Fourth Quarter and Year End Financial Results 4PDI Reports 2011 Fourth Quarter and Year End Financial Results 5PDI Reports 2011 Fourth Quarter and Year End Financial Results 6PDI Reports 2011 Fourth Quarter and Year End Financial Results 7PDI Reports 2011 Fourth Quarter and Year End Financial Results 8PDI Reports 2011 Fourth Quarter and Year End Financial Results 9PDI Reports 2011 Fourth Quarter and Year End Financial Results 10Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 2Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 3Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 4Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 5
(Date:7/9/2014)... printing on prescription labels handed out by pharmacists ... in taking medication, according to new research by ... Institute for the Blind)., The study, published recently ... that labels on prescription medications dispensed by pharmacies ... legibility. , By simply following recommended guidelines for ...
(Date:7/9/2014)... A study published in the scientific journal ... Bonin, two researchers at Universit Laval, reveals that it ... method that involves rekindling pain so that it can ... means to alleviate chronic pain. , The researchers from ... universitaire en sant mentale de Qubec (IUSMQ) were inspired ...
(Date:7/8/2014)... similar longevity and cardiovascular health as other healthy mature ... American Journal of Transplantation . The findings may ... the transplant professionals caring for them. , Over the ... 55 years and older has become more common. Given ... disease, the removal of a kidney could make older ...
(Date:7/8/2014)... from Plymouth, UK, and Sydney, Australia, have today (Wednesday ... ACEmobile - a free-to-use app to support the assessment ... first of its kind; an iPad-based tool that supports ... the whole process, meaning more members of the clinical ... assessment. Designed by clinicians for clinicians, ACEmobile also collects ...
(Date:7/8/2014)... a biomarker that could give expecting mothers and their ... that a pregnant woman may develop preeclampsia, at least ... Preeclampsia is a cardiovascular disorder generally occurring late in ... immediate and potentially lifelong risks to both mother and ... the urine, and is typically diagnosed in the late ...
Breaking Medicine News(10 mins):Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2Health News:Discovery of a new means to erase pain 2Health News:Study finds kidney donation safe for healthy older adults 2Health News:New app widens opportunities for dementia assessments 2Health News:New app widens opportunities for dementia assessments 3Health News:UI researchers find early predictor for preeclampsia 2Health News:UI researchers find early predictor for preeclampsia 3
... series feature eight model methods for effective prospect ... has released its first in a series of ... are using prospect research efficiently and with success ... fundraising, includes survey responses from 60 hospitals and ...
... 1 on annual listOAKLAND, Calif., March 5 ... has been recognized by DiversityMBA ... organization was ranked No. 1 in the publication,s fourth ... for Diverse Managers to Work," which will hit newsstands ...
... To Beaver, Star Jerry MathersJACKSON, Miss., March 5 ... will be stopping in Mississippi the week of March ... to help uninsured and financially-struggling Mississippians access information on ... free. With the unemployment rate in Mississippi (7.8 percent) ...
... for low intake of Omega-3 EPA/DHA amongst , childrenHALIFAX, ... the Journal of Nutrition found that most Canadian children ... 78% of the children trialed were not receiving adequate ... , Researchers from the University of Guelph ...
... ANGELES, March 5 With the nation focused on ... recently announced Assembly Bill 562 ( AB ... businesses and consumers that have fallen victim to price ... health care premium costs. It requires insurance companies to ...
... 5 Ascension Insurance, Inc. has announced ... Lauderdale, effective January 16th 2009. The agency specializes in ... (EMI), a member of the Ascension group of companies ... the Ascension group is managed by Ascension Insurance, Inc. ...
Cached Medicine News:Health News:WealthEngine Releases Best Practices Report for Healthcare Fundraising 2Health News:Kaiser Permanente Recognized as Best Place for Diverse Managers 2Health News:Kaiser Permanente Recognized as Best Place for Diverse Managers 3Health News:Partnership for Prescription Assistance Prepared to Help Mississippi Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Mississippi Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Mississippi Workers Hurt by Recession 4Health News:North American Children are Omega-3 Deficient and may be at risk for Suboptimal Health 2Health News:North American Children are Omega-3 Deficient and may be at risk for Suboptimal Health 3Health News:North American Children are Omega-3 Deficient and may be at risk for Suboptimal Health 4Health News:New Health Care Legislation Stops 'Opportunistic' Insurance Pricing 2Health News:Ascension Insurance, Inc. Acquires Fort Lauderdale-based Dennis Bartlett Agency 2
Our 2.5v Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
... are standard in all Welch Allyn ... students, the 18335-SDS combines the superior ... the superior illumination of the Halogen ... of the Finnoff Transilluminator, and the ...
Our 2.5v Streak Retinoscope Sets feature instruments with bright light, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Medicine Products: